INTRODUCTION
In contrast to epigenetic regulations of DNA and histones, which have been intensively studied (Jenuwein and Allis, 2001; Klose and Zhang, 2007; Kohli and Zhang, 2013; Strahl and Allis, 2000; Suzuki and Bird, 2008) , only recently have researchers begun to appreciate the importance of reversible RNA modifications in regulating gene expression He, 2010) . The discoveries of the ''writer, '' ''reader,'' and ''eraser'' proteins of the N 6 -methyladenosine (m 6 A) of mRNAs and certain long noncoding RNAs (lncRNAs) have opened a new realm of dynamic regulation of gene expression at the post-transcriptional level (Dominissini et al., 2012; Jia et al., 2011; Liu et al., 2014; Ping et al., 2014; Wang et al., 2014 Wang et al., , 2015 Zheng et al., 2013) . Defects of the m 6 A methyltransferase complex result in a battery of development problems in various eukaryotic species (Yue et al., 2015) . The YTH domain proteins, the m 6 A readers, influence the stability, translation, and splicing of the m 6 A-containing mRNAs (Wang et al., , 2015 Xiao et al., 2016; Xu et al., 2014; Zhou et al., 2015) .
Two RNA m 6 A demethylases, FTO and ALKBH5, have been identified since 2011 as being capable of removing the methyl group of m 6 A on poly-adenylated RNA through an iron-dependent oxidative demethylation mechanism (Fu et al., 2013; Jia et al., 2011; Zheng et al., 2013) . These two demethylases have been shown to impact human body weight (Dina et al., 2007; Do et al., 2008; Frayling et al., 2007) and mouse fertility (Zheng et al., 2013) , respectively. Thus far, m 6 A is the only documented reversible RNA modification that impacts the metabolism and fate of RNA (Dominissini et al., 2012; Liu et al., 2015; Meyer et al., 2012; Wang et al., 2014 Wang et al., , 2015 , although new dynamic marks have recently been identified on mRNA (Dominissini et al., 2016; Li et al., 2016) .
All the aforementioned studies reveal the prominent importance of the dynamic mRNA modifications in affecting gene expression. tRNAs are known to be heavily modified (Phizicky and Hopper, 2010; Suzuki and Suzuki, 2014; El Yacoubi et al., 2012) . Many tRNA modifications affect cell viability, fitness, development, and a range of other cellular functions (Anderson et al., 1998; Begley et al., 2007; Chan et al., 2012; Kaiser et al., 2014; Saikia et al., 2010; Songe-Møller et al., 2010) . However, a reversible tRNA modification process that could noticeably affect gene expression has yet to be shown.
FTO and ALKBH5 are RNA demethylases that belong to the human AlkB family dioxygenases that utilize a nonheme iron(II) to catalyze biological oxidation (Falnes et al., 2002; Gerken et al., 2007; Loenarz and Schofield, 2008; Trewick et al., 2002) . Almost all of the AlkB family members with known biological functions work on nucleic acid substrates (Fedeles et al., 2015) . Human ALKBH1 is another member of the AlkB family proteins. The deletion of Alkbh1 in mice could lead to embryonic lethality, with the survived mice exhibiting neural development defects and sex-ratio distortion (Nordstrand et al., 2010; Ougland et al., 2012; Pan et al., 2008) . The exact molecular function of ALKBH1 remains elusive, although DNA has been suggested as a potential substrate (Mü ller et al., 2010; Westbye et al., 2008) .
Here, we present ALKBH1 as an RNA demethylase that mediates removal of the methyl group from N 1 -methyladenosine (m 1 A) in tRNA. We further show that ALKBH1 can tune translation initiation and elongation by regulating the cellular levels of tRNA iMet and the association of other ALKBH1 target tRNAs to polysomes, respectively, thereby affecting protein synthesis. This discovery reveals a new pathway and mechanism of translation control through reversible tRNA methylation.
RESULTS

ALKBH1 Binds tRNA inside Cells
We utilized crosslinking and immunoprecipitation (CLIP) (Ule et al., 2005) followed by gel analysis to probe and identify potential RNA species bound by ALKBH1 in HeLa cells. To our surprise, CLIP identified mature tRNAs as main RNA species bound by ALKBH1 ( Figure 1A ). We subsequently performed high-throughput sequencing of the RNA products obtained from CLIP. Although reverse transcription and amplification of tRNAs are known to be significantly inhibited because of their heavily modified nature as compared to other RNA species (Cozen et al., 2015; Mohr et al., 2013) , replicate experiments consistently showed that certain tRNAs are enriched in the ALKBH1-based CLIP products compared to the total RNA control using small RNA library preparation (Figures S1A and S1B). The composition of these tRNA species bound by ALKBH1 is quite different from that of cellular tRNAs in HeLa cells (Figures 1B and 1C) . Further analysis of all tRNAs enriched in the CLIP products of ALKBH1 indicates that all of them contain the m 1 A58 modification (Machnicka et al., 2013) .
Intrigued by this observation, we performed protein sequence alignments of ALKBH1 with known tRNA-binding motifs. Indeed, we found that ALKBH1 possesses a tRNA-binding domain that is used by eukaryotic tRNA ligases to recognize tRNAs ( Figure S1C ) (Ghosh and Vishveshwara, 2007; Nakanishi et al., 2005 ).
The tRNA m 1 A Demethylation by ALKBH1 The CLIP results suggested that tRNAs are potential substrates of ALKBH1. We thus tested whether ALKBH1 exhibits biochemical activity on tRNA by treating the purified total tRNA from HeLa cells with recombinant ALKBH1 protein. The levels of known tRNA methylations including m 1 A, m 7 G, m 5 C, and m 3 C were measured with ALKBH1 treatment in the presence or absence of EDTA (EDTA chelates iron and inhibits the demethylation activity) using liquid chromatography-tandem mass spectrometry (LC-MS/MS, Figure S1D ) (Jia et al., 2011; Zheng et al., 2013) . Incubation of total tRNA with ALKBH1 led to a dramatic decrease of the m 1 A level, but not levels of m 7 G, m 5 C, or m 3 C, in comparison to the control samples ( Figure 1D ; Figure S2A ), suggesting that m 1 A58 in tRNAs is a major substrate of ALKBH1 ( Figure 1E ); m 1 A58 has been shown to be the predominant m 1 A modification in tRNAs as revealed by recent m 1 A sequencing experiments (Cozen et al., 2015; Tserovski et al., 2016) . To analyze the observed tRNA demethylation, ALKBH1 was transiently knocked down or overexpressed in HeLa cells, and the level of m 1 A was quantified using LC-MS/MS. An $6% increase and an $16% decrease of the m 1 A level in total tRNA was consistently observed in the knockdown and overexpression samples, respectively ( Figure 2A ). Moreover, an ALKBH1 stable overexpression HeLa cell line showed an $28% decrease of the m 1 A level in tRNA compared to control cells. We also studied the Alkbh1 homozygous knockout (Alkbh1
) mouse embryonic fibroblast (MEF) cells that we obtained previously (Nordstrand et al., 2010) . We observed an $42% increase of the m 1 A level in tRNA from the Alkbh1 À/À MEF cells in comparison to the wild-type MEF cells ( Figure 2B ). A dot-blot assay using an m 1 A-specific antibody was also applied to the same samples, and results were consistent with LC-MS/MS measurements ( Figures S2B and S2C ). As expected, neither knockdown nor overexpression of ALKBH1 caused any changes of the levels of m 7 G, m 5 C, or m 3 C in total tRNA ( Figure S2D ).
Because the m 1
A level of the total tRNA is significantly affected by ALKBH1 (Figures 2A and 2B ) and all tRNAs identified by CLIP contain m 1 A58 ( Figure 1B) , we further validated the m 1 A demethylation activity of ALKBH1 on selected target tRNAs. Biotin-labeled DNA probes complementary to tRNA species were used to specifically isolate the corresponding tRNA from HeLa and MEF cells ( Figure S2E Figure 2C ; Table S1 ). Likewise, we measured the m 1 A levels of these tRNAs in the ALKBH1 stable overexpression HeLa cell line and the control cell line. Results again revealed that overexpression of ALKBH1 led to reduced m 1 A in these tRNAs ( Figure 2D ). Therefore, the majority of tRNAs identified by CLIP-sequencing (CLIP-seq) are substrates of ALKBH1. Taking tRNA His(GUG) as an example, which has a relatively high m 1 A level, an $65% increase and an $39% decrease of the m 1 A/G ratio were observed in the Alkbh1 knockout and ALKBH1 overexpression cells compared to corresponding controls, respectively. Figure S2F ). Similar measurements were performed on mRNA, and the results showed that ALKBH1 does not noticeably affect the mRNA m 6 A level ( Figure S2G ). Biochemical experiments further confirmed that m 6 A in RNA is less likely a substrate of ALKBH1
( Figure S2H ). We observed a slight increase of the total m 1 A in mRNA in See also Figure S1 . , tRNA His(GUG) , tRNA Gln(CUG) , t R N A Lys(yUU) , tRNA Ala(hGC) ,
, tRNA Asn(GUU) , and tRNA ratio in these tRNAs compared to controls. p values were determined using two-tailed Student's t test for paired samples. Error bars represent mean ± SD, n = 8 (four biological replicates 3 two technical replicates). *p < 0.05, **p < 0.01. See also Figure S2 and Lastly, DNA N 6 -methyldeoxyadenosine (6mA) has been proposed as a substrate of ALKBH1 in a recent study (Wu et al., 2016) . Our biochemical assay did not reveal observable DNA 6mA demethylation activity by ALKBH1 ( Figure S2H ). In addition, we have measured the genomic DNA N 6 -methyldeoxyadenosine (6mA) levels in Alkbh1 +/À and Alkbh1 À/À mESCs without noticeable changes of 6mA observed ( Figure S2J ). and tRNA Sec(UCA) did not appear to be affected by ALKBH1 (Figures S3A and S3B) ; these tRNAs are not among CLIP targets found for ALKBH1 and tRNA Sec(UCA) that are known to possess structural features distinct from other tRNAs (Itoh et al., 2009 (Anderson et al., 1998 Figure S3C ). Genome-wide tRNA sequencing was performed to estimate levels of every tRNA species in the Alkbh1 À/À and control cells .
ALKBH1 Affects
The result showed modest change for many tRNAs in the Alkbh1 À/À cells compared to the wild-type control; however, the level of tRNA iMet was increased by $1.9-fold ( Figure S3D ). Figure 3A ).
Our observations suggest that tRNA iMet is a substrate of ALKBH1 and that the ALKBH1-mediated m 1 A58 demethylation may affect the stability of tRNA iMet , which could impact the global programming of tRNAs. The cellular level of tRNA iMet is known to significantly impact translation initiation and cell proliferation (Macari et al., 2016; Pavon-Eternod et al., 2013) . Indeed, a noticeably increased cell proliferation was observed in the ALKBH1 knockdown cells compared to control cells ( Figure 3B ). To probe the impact of the elevated tRNA iMet caused by ALKBH1 knockdown on translation initiation, a key step critical to cell proliferation, we treated the ALKBH1 knockdown and control HeLa cells with ribosome E site inhibitor lactimidomycin (LTM) and separated the initiating ribosome . We measured the absolute levels of tRNA iMet in the initiating ribosome and the total RNA with 5s rRNA as the loading control. We consistently observed that ALKBH1 knockdown leads to increased cellular tRNA iMet as well as increased tRNA iMet in the initiating ribosome ( Figure 3C ; Figure S3F ). The polysome profile results support increased 80S monosome assembly upon ALKBH1 knockdown ( Figure S3G ). Taken together, the elevated tRNA iMet induced by ALKBH1 knockdown promotes translation initiation and cell proliferation as a functional consequence. We separated tRNA in the translation-inactive non-polysome fractions (< 80S) as well as tRNA associated with translationactive polysomes (> 80S) from HeLa cells. Three selected tRNAs (tRNA Val(mAC) , tRNA His(GUG) , and tRNA Gly(GCC) ) were subsequently extracted from these fractions using biotinylated cDNA probes that are specific for each tRNA. LC-MS/MS measurements confirmed that the m 1 A-hypermodified tRNA Val(mAC) , tRNA His(GUG) , and tRNA Gly(GCC) preferentially associate with the translation-active polysomes ( Figure 4A ). We further examined HeLa cells with stable overexpression of ALKBH1, in which tRNA His(GUG) and tRNA Gly(GCC) were hypomethylated. Northern blot analysis revealed significantly reduced populations of these two tRNAs (73% reduction for tRNA Gly(GCC) and 57% reduction for tRNA His(GUG) ) in the translationally active pool versus the inactive pool ( Figures S4A and S4B ).
We next studied how m 1 A-methylated tRNAs might be preferentially recognized and delivered to translation-active polysomes. We pulled down eEF1a, the elongation factor protein known to deliver aminoacyl tRNA to translation-active polysomes, from HeLa cells using an anti-eEF1a specific antibody ( Figure S4C ). The immunoprecipitated eEF1a was incubated with total tRNA purified from the same cells. We observed an $2.5-fold enrichment of m 1 A in the eEF1a-bound fraction ( Figure 4B ), confirming enrichment of m 1 A-methylated tRNAs in the translation-active pool. eEF1a may preferentially bind m 1 A-methylated tRNA. It is also possible that the methylated tRNAs are preferentially aminoacylated and subsequently recognized by eEF1a, although fully unmodified tRNAs can be readily charged in vitro and many tRNA synthetases are not known to interact with the tRNA region where m 1 A58 resides (Giegé et al., 1998) .
The ALKBH1-Mediated tRNA Demethylation Impacts Translation Elongation
In order to confirm the effect of the ALKBH1-dependent tRNA demethylation on protein synthesis, we used an alkyne-modified glycine analog, L-homopropargylglycine (HPG), to metabolically label newly synthesized proteins in Alkbh1
and wild-type MEF cells as well as in ALKBH1 stable overexpression HeLa cells versus control cells. The HPG-labeled cells were then fluorescently modified and analyzed by flow cytometry. The results showed a notable increase of protein synthesis rate in the Alkbh1 À/À cells compared to the wild-type cells. In contrast, ALKBH1 overexpression led to a reduction of the protein synthesis rate compared to the control ( Figure 4C ; Figures S4D-S4I ).
These results are consistent with the promotion of the translation initiation by the knockdown of ALKBH1. The results also support the preferential recruitment of m 1 A-methylated tRNAs to the active translation pool, which promotes translation elongation. Because we observed up to a 3-fold change of the total cellular tRNA iMet level and an $2-fold increase of tRNA iMet in initiating ribosome with ALKBH1 knockdown inside HeLa cells, the effect of ALKBH1 on translation initiation is significant. To investigate the translation elongation effect of ALKBH1 that is independent of translation initiation, we first designed a reporter assay with six repeated specific codon sequences [6 3 CAC(His) for tRNA His(GUG) and 6 3 GGC(Gly) for tRNA Gly(GCC) ] added to the 5 0 of firefly luciferase (F-luc) ( Figure 5 ); a second Renilla luciferase (R-luc) encoded in the same plasmid was used to normalize the expression efficiency. To further normalize translation differences between Alkbh1 À/À and wild-type MEF cells introduced by any other factor including initiation (i.e., the cellular levels of tRNA iMet and other tRNAs), a control reporter (F-luc plus R-luc) devoid of these 6 3 sequences was also transfected. The normalization factor from this control reporter was applied to the 6 3 CAC(His)-reporter signal. For the mRNA reporter fused with 6 3 CAC(His), an $1.6-fold-elevated translation was observed in the Alkbh1 À/À MEF cells compared to the wildtype MEF cells ( Figure 5A ). Similarly, 6 3 GGC(Gly) was inserted in the reporter plasmid. tRNA Gly(GCC) cannot decode the GGA codon; therefore, we also inserted 6 3 GGA(Gly) into a negative control reporter. We observed elevated translation ($1.8-fold) for the 6 3 GGC(Gly)-reporter in the Alkbh1 À/À cell compared to the wild-type MEF cells, but not the negative control reporter with 6 3 GGA(Gly) sequences ( Figure 5B ). We further constructed two mutant reporters with selected codons mutated from matching tRNA anti-codons that are substrates of ALKBH1 to codons matching isoacceptor tRNAs that are not substrates of ALKBH1 ( Figure S5 ). Mutant reporter 1 contained mutations of three codons (Lys8, Lys9, See also Figure S3 . and Gly10; see Method Details) and mutant reporter 2 contained mutations of three codons (Ala64, Ala66, and Lys68; see Method Details) of F-luc, respectively. We transfected the mutant reporters with the wild-type reporter control to ALKBH1 knockdown cells and control cells, respectively. We observed that the mutations led to noticeably reduced protein synthesis when normalized to the control reporter (without mutations) upon ALKBH1 knockdown (Figures S5A and S5B) . Together, these results indicate that a deficiency of ALKBH1 leads to increased m 1 A levels of specific tRNAs and augments translation elongation from the corresponding codons.
An ALKBH1-Dependent Translation Control in Responses to Glucose Deprivation
We then investigated the dynamics of ALKBH1 under different physiological conditions. We noticed an increased expression of ALKBH1 in HeLa cells under glucose deprivation conditions, while the level of the m 1 A58 methyltransferase heterodimer Trmt6/Trmt61 remained mostly unchanged ( Figure 6A ; Figure S6) . The elevated ALKBH1, induced by the reduced glucose concentration in the growth medium, led to progressively decreased m 1 A methylation in tRNA His(GUG) and tRNA Gly(GCC) as expected ( Figure 6B ); the expression level of tRNA iMet also decreased under glucose deprivation, which can be reversed by the knockdown of ALKBH1 ( Figure 6C ). After treating cells with ribosome E site inhibitor LTM and separating the initiating ribosome, we measured the levels of tRNA iMet in the initiating ribosome. The knockdown of ALKBH1 induced a noticeable increase of tRNA iMet in the initiating ribosome in comparison to the knockdown control, indicating a translation repressing role of ALKBH1 ( Figures 6C and 6D ). The inhibition of translation initiation induced by the elevated ALKBH1 is likely a mechanism cells employ to globally repress translation upon glucose deprivation.
To examine effects on translation elongation with elevated ALKBH1 upon glucose deprivation, we again employed the 6 3 CAC(His)-reporter normalized to the control ( Figure 5A ) in HeLa cells growing with different concentrations of glucose. Significantly decreased protein synthesis from the reporter mRNA was observed in cells growing in the medium with reduced glucose; this effect could again be reversed by the transient knockdown of ALKBH1 ( Figure 6E ). In addition, the knockdown of ALKBH1 in HeLa cells (growing at 25 mM glucose) resulted in an increased translation of the 6 3 CAC(His)-reporter ( Figure 6F ). This effect could be reversed by transient overexpression of the wild-type ALKBH1, but not a catalytically inactive ALKBH1 H231A/D233A mutant, further confirming that the ALKBH1-catalyzed demethylation affects protein synthesis in response to the availability of glucose ( Figure 6G ). With mutant reporters ( Figure S5 ) we also observed that the mutations led to noticeable increases in the normalized protein synthesis over the control reporter upon glucose starvation ( Figure S5C ), consistent with the elevated cellular ALKBH1 in glucose starving cells. Thus, ALKBH1 can affect both translation initiation and translation elongation upon glucose deprivation. , tRNA His(GUG) , and tRNA Gly(GCC) preferentially associate with the polysomes. Quantification of the m 1 A/G ratio in tRNA Val(mAC) , tRNA His(GUG) , and tRNA Gly(GCC) extracted from the translationally inactive portions (< 80S) and the translationally active portions (> 80S) in ALKBH1 stable overexpression HeLa cells and the control cells. Error bars represent mean ± SD, n = 8 (four biological replicates 3 two technical replicates).
(B) The elongation factor-1 protein (eEF1a) was pulled down from HeLa cells using a specific anti-eEF1a antibody and then incubated with an excess amount of total tRNA purified from same cells. LC-MS/MS measurements showed enrichment of m 
DISCUSSION
Here, we report ALKBH1 as a tRNA demethylase that catalyzes demethylation of m 1 A in tRNAs. A tRNA-binding motif exists in ALKBH1, and it preferentially demethylates m 1 A in a stem-loop structure. CLIP sequencing data showed that ALKBH1 binds m 1 A58-containing tRNAs. Further biochemistry characterizations revealed that ALKBH1 possesses effective tRNA m 1 A demethylation activity in vitro and inside cells. We showed that ALKBH1 controls cellular levels of tRNA iMet to affect translation initiation and that the m 1 A-methylated tRNAs are preferentially recruited to polysomes to promote translation elongation. The ALKBH1-mediated tRNA demethylation controls the utility of the target tRNAs in translation, thereby directly influencing protein synthesis. This process is dynamic and is used by human cells to respond to glucose deprivation. This discovery opens a potential new paradigm of reversible tRNA methylation in affecting gene expression.
Nucleic Acid Substrate(s) of ALKBH1 ALKBH1 has been suggested to work on nucleic acid substrates in the past (Fedeles et al., 2015) . A recent publication describes ALKBH1 as a 6mA demethylase (Wu et al., 2016) . We have tested the activity of ALKBH1 toward 6mA in DNA in vitro and inside cells. The reported demethylase activity toward 6mA DNA was too low to be observed in our experiments ( Figure S2H ). Although we could not completely exclude 6mA in DNA as a substrate of ALKBH1, all of our biochemical studies of the same mESC lines as well as other mammalian cell lines do not currently support 6mA in DNA as a substrate of ALKBH1. ALKBH1 possesses a tRNA-binding motif. Our CLIP sequencing data and demethylation activity analysis of ALKBH1 indicate that ALKBH1 binds and acts preferentially on tRNA over mRNA in cell lines we studied. If ALKBH1 can gain access to mRNA, it is possible that ALKBH1 may also mediate mRNA m 1 A demethylation to affect specific developmental or cellular processes in mammalian systems, which should be investigated in the future. A recent publication by Haag et al. (2016) showed that ALKBH1 also oxidizes m 5 C34 to 5-formyl-cytosine (f 5 C) in mitochondrial tRNA iMet , suggesting an additional tRNA modification function of ALKBH1 in a distinct cellular compartment.
tRNA m 1 A Demethylation by ALKBH1 The m 1 A methylation endows tRNA with a positive charge that can significantly affect its structure and interaction with potential partner proteins. This methylation is known to be critical to the stability of tRNA iMet (Anderson et al., 1998) . (B) Scheme of the reporter assay on the left. The effect of tRNA Gly(GCC) in protein translation was revealed by a reporter assay. 6 3 GGC(Gly)-coding sequences were inserted after the promoter region of F-luc as the positive reporter [noted as 6 3 GGC(Gly)]; 6 3 glycine-coding sequences of GGA(Gly) were fused to the 5 0 end of F-luc as the negative control [noted as 6 3 GGA(Gly)]; another control vector is devoid of any amino acid insertion (noted as control). The insertion of 6 3 GGC(Gly)-coding sequences in the luciferase reporter led to an $1.8-fold increased protein translation in the Alkbh1 À/À MEF cells compared to the wild-type MEF cells; this effect was not observed with the negative control of 6 3 GGA(Gly) insertion. The control reporter without any insertion was used to normalize the translation differences between the two cells lines. Error bars represent mean ± SD, n = 12 (three biological replicates 3 four technical replicates). See also Figure S5 .
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(legend on next page) (Dominissini et al., 2016; Li et al., 2016) . ALKBH3, a DNA repair enzyme that demethylates N 1 -methyldeoxyadenosine in singlestranded DNA (Aas et al., 2003; Duncan et al., 2002) , has been suggested as a potential demethylase of m 1 A in mRNA , the functional relevance of which still requires further investigations. ALKBH3 is also capable of repairing tRNA alkylation damages (Aas et al., 2003) ; again, the biological relevance of which was not clear. We show that m 1 A in tRNA is the main substrate of ALKBH1. Many tRNA species contain this methylation (Machnicka et al., 2013) , with a substantial fraction of which subjected to ALKBH1-mediated demethylation.
The cellular level of tRNA iMet can be significantly affected by ALKBH1, suggesting an ALKBH1-mediated demethylation of m 1 A58 of tRNA iMet . m 1 A58 is essential for the stability and function of tRNA iMet in yeast (Anderson et al., 1998) ; this is also likely to be the case in humans. In human cells, it is possible that ALKBH1 encounters tRNA iMet and catalyzes its m 1 A58 demethylation, which then leads to tRNA iMet degradation. Subsequent dissociation of ALKBH1 from tRNA iMet may explain the lack of tRNA iMet as a binding substrate of ALKBH1 in the CLIP result.
Importantly, we observed significant effects of ALKBH1 on the total cellular tRNA iMet level and subsequent translational initiation.
Translation Regulation through Reversible tRNA Methylation
Translational control is an essential means in the regulation of gene expression in a myriad of cellular events. The pathways of translation regulation are complex in mammals, reflecting the complexity of mammalian development, signaling, and response to environmental cues. Global regulation of translation is often done by influencing the activity of the translation initiation factors and the availability of the ribosomes (Gebauer and Hentze, 2004; Hershey et al., 2012) . The rate-limiting step in translational control is typically at the initiation step. Phosphorylation of eIF2a, 4E-BPS, and other initiation factors negatively impacts translation (Pavitt and Ron, 2012) . In addition to the regulation of translation initiation, mRNA can be sequestered into stress granules or P-bodies upon translation inactivation in response to stresses (Decker and Parker, 2012) . Nonsense-mediated decay ensures translation fidelity by screening mRNAs for premature stop codons and mediating their decay (Hentze and Kulozik, 1999; Maquat, 2004) . In contrast to the global translational regulation, microRNA can attenuate translation by interacting directly to the target mRNAs (Bartel, 2009; Ha and Kim, 2014) . Trans-acting proteins can affect translation rate by specifically recognizing a particular mRNA site, such as the 3 0 UTR (Gebauer et al., 2012) . Dynamic RNA modifications also emerged as a new type of regulatory mechanism of translation. For instance, the m 6 A reader protein YTHDF1 specifically associates with the m 6 A sites and promotes translation by interacting with the translation initiation complex (Wang et al., 2015) . The recently identified mRNA modification m 1 A in mRNA is suggested to be related to active translation as well (Dominissini et al., 2016; Li et al., 2016) , although the m 1 A-binding protein and the underlying mechanism have yet to be unveiled. tRNA modifications have long been thought to affect translation by fine-tuning tRNA structures and their interactions with the corresponding mRNA codons (Agris, 2008; Agris et al., 2007) . Most of the known cases involve tRNA modifications that impact specific tRNAs. For example, m 1 A58 is indispensable for the proper folding of tRNA iMet ; under stressed conditions, such as heat shock, the loss of m 1 A58 results in tRNA iMet degradation (Wang et al., 2008) . We show here that a group of tRNAs can be subjected to a more global regulation through the ALKBH1-mediated demethylation of a common m 1 A modification. tRNAs are abundant in all cells; however, the m 1 A-modified tRNAs, at least those that are ALKBH1 substrates, preferentially associate with polysomes to support translation. The current work represents the discovery of the first tRNA demethylase and the first reversible tRNA modification that could broadly affect protein synthesis. Cytosine-5 RNA methylation has very recently been shown to protect tRNA from cleavage and modulate global protein synthesis and cell fate (Blanco et al., 2016) . The ALKBH1-mediated tRNA demethylation directly affects translation initiation by controlling the cellular levels of tRNA iMet and impacts translation elongation by tuning the methylation status and availability of (C) Glucose deprivation decreased the cellular level of tRNA iMet , which could be reversed by ALKBH1 knockdown (5s rRNA was used as the loading control).
Glucose deprivation also noticeably decreased the level of tRNA iMet in the initiating ribosome. The knockdown of ALKBH1 led to elevated tRNA iMet in the initiating ribosome in comparison to the control in HeLa cells cultured with 5 mM and 25 mM glucose, respectively. 500 ng of total RNA extracted from the initiating ribosomes were applied in the northern blot analysis. One representative result was shown.
(D) The levels of tRNA iMet as shown in (C) were quantified by using Quantity One.
(E) The 6 3 CAC(His)-reporter assay showing increased translation in HeLa cells with elevated glucose levels in the culture medium. This effect could be reversed by transient knockdown of ALKBH1. Error bars represent mean ± SD, n = 12 (three biological replicates 3 four technical replicates).
(F) Knockdown of ALKBH1 in HeLa cells growing at 25 mM glucose led to an increased translation of the 6 3 CAC(His)-reporter. The effect could be reversed by transient overexpression of the wild-type ALKBH1, but not a catalytically inactive ALKBH1 H231A/D233A mutant. p values were determined using two-sided Student's t test for paired samples. *p < 0.05, **p < 0.01. Error bars represent mean ± SD, n = 12 (three biological replicates 3 four technical replicates).
(G) A proposed model of ALKBH1-dependent regulation of translation. The m 1 A58 methylated tRNAs are preferentially used in the translation-active pool; the ALKBH1-mediated tRNA m 1 A demethylation, which responds to the glucose deprivation, tunes the association of specific tRNAs to polysomes and thus represses protein synthesis. See also Figure S6 .
target tRNAs. These effects enable rapid responses to cellular signaling cues, such as the glucose deprivation shown in this work ( Figure 6G ). Severe embryonic development defects had been reported in Alkbh1 knockout mice (Nordstrand et al., 2010) . The survived Alkbh1 knockout mice show defects in tissues originating from the ectodermal lineage (Pan et al., 2008) and impaired neuronal development (Ougland et al., 2012) . These phenotypes all indicate the functional significance of ALKBH1 in mammals. Our previous discoveries of FTO and ALKBH5 as mRNA m 6 A demethylases sparked the emergence of the epitranscriptomics field (Jia et al., 2011; Zheng et al., 2013) . The discovery presented here, on tRNA m 1 A demethylation by ALKBH1, should stimulate future studies on reversible tRNA methylation in translation control and its impacts on mammalian developments.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Table S2 This paper N/A See summary of tRNA m1A58 methylation in human tRNAs in Table S1 Machnicka Cozen et al., 2015 N/A
METHOD DETAILS
Luciferase Reporter Assay pmirGlo luciferase expression vector (Promega) was used to construct the reporter plasmid, which contained both a firefly luciferase (F-luc), and a Renilla luciferase (R-luc). F-luc-6 3 His(CAC) reporter plasmid was obtained by inserting CACCACCACCACCACCAC before the F-luc coding region; F-luc-6 3 Gly(GGC) reporter plasmid was obtained by inserting GGCGGCGGCGGCGGCGGC before the F-luc coding region; F-luc-6 3 Gly(GGA) reporter plasmid was obtained by inserting GGAGGAGGAGGAGGAGGA before the F-luc coding region. Two F-luc mutant reporters were made by using site-directed mutagenesis. For mutant reporter 1, the sequences of Lys8, Lys9, and Gly10 were mutated from the tRNA anti-codons being the substrates of ALKBH1 to the ones not. For mutant reporter 2, the sequences of Ala64, Ala66, and Lys68 were mutated from the tRNA anti-codons being the substrates of ALKBH1 to the ones not. Basic setting: 500 ng of reporter plasmids (pmirGlo empty vector or pmirGlo-specific tRNA anti-codon inserted vector) were transfected into Alkbh1 À/À and wild-type MEF cells in a six-well plate. After 6 hr, each well was re-seeded into a 96-well plate (1:20). After 24 hr, the cells in 96-well plate were assayed by Dual-Glo Luciferase Assay system (Promega). Renilla Luciferase (R-luc) was used to normalize firefly luciferase (F-luc) activity to evaluate the translation efficiency of the reporter. Glucose deprivation was applied 4 hr after the reporter plasmids were transfected and kept for another 12 hr prior to the luciferase assay.
CLIP 10 plates of HeLa cells in 15 cm petri dish were grown until confluency of 80% ($8 million cells). The medium was aspirated and 5 ml of ice-cold PBS was subsequently added to the culture dish. Cells were irradiated once with 400 mJ/cm 2 at 254 nm in Stratalinker on ice. After irradiation, cells were harvested by centrifugation at 4000 rpm for 3 min at 4 C. The cell pellets were then lysed in lysis buffer (1 3 PBS supplemented with 0.1% SDS, 1% Nonidet P-40, 0.5% Sodium Deoxycholate, Protease Inhibitor Cocktail (1 tablet/50 ml) and RNase inhibitor) and kept on ice. After 4 hr of incubation, the cell pellets were subjected to centrifugation at 17,000 g at 4 C for 30 min; the supernatant was carefully collected. 50 ml of protein A beads were added into the supernatant to preclear the supernatant at 4 C for 1 hr which was then subjected to centrifugation at 17,000 g at 4 C for 10 min. The supernatant was collected in a fresh tube. 50 ml of antibody-conjugated protein A beads were subsequently added to the supernatant and kept at 4 C for overnight with rotation. On the next day, the supernatant was discarded. The beads were then washed for 3 times with 1 ml of high salt buffer (5 3 PBS supplemented with 0.1% SDS, 1% Nonidet P-40 and 0.5% Sodium Deoxycholate) and another 3 times with 1 ml of wash buffer (20 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 and 0.2% Tween-20). The RNAs were then isolated by 200 ml of elution buffer (100 mM Tris-HCl, pH 7.4, 10 mM EDTA, and 1% SDS) containing 2 mg/ml proteinase K under incubation at 50 C for 30 min. Subsequently, the sample was subjected to centrifugation at 17,000 g at 4 C for 15 min. The beads were removed and RNAs were recovered by Phenol/chloroform extraction. The RNA species were then 3 0 32 P-labeled and subjected to TBE-Urea-PAGE separation. eEF1a and IgG were employed as positive and negative controls in this experiment while human total tRNA was utilized as a size marker for intact tRNA. The TBE-Urea gel was finally exposed to phosphoimager.
Analysis of RNA Sequencing Results
(1) CLIP Raw reads from CLIP samples were first trimmed according to recommended settings using Trimmomatic with a minimum length of 25 nucleotides (Bolger et al., 2014) . Processed reads were then mapped to the hg19 genome using bowtie with the following settings (-v 2 -m 10 -best -strata -p 12), and the subsequent SAM outputs were analyzed with default PARalyzer parameters. From genomic coordinates, refseq IDs and region ID (genomic, tRNA, intergenic, rRNA, etc.) were assigned using custom scripts in order to classify PARalyzer clusters. Conversion rate and cluster assignment and enrichment were determined using custom Python scripts from PARalyzer output. Ratios of each class of small RNAs in the total RNA dataset were calculated and compared to the RNA classes in the CLIP dataset.
(2) tRNA Seq Data analysis method was adapted from our previous work . Briefly, tRNA-seq raw reads were trimmed and processed using Trimmomatic (Bolger et al., 2014 ) with a minimum length of 16 nucleotides. Processed reads were then aligned with bowtie2 to culled tRNA fasta libraries from the Genomic tRNA database for mm10 and hg19 with CCA appended to every sequence. Bowtie2 parameters were sensitive settings, which allowed for up to 2 mismatches. Reads mapping to multiple isodecoders were discarded. Downstream isodecoder abundance was performed using custom Python scripts.
Cloning, Expression, and Purification of ALKBH1
The human ALKBH1 gene (GenBank: NM_006020.2) with deletion of the N-terminal 36 amino acids was subcloned into a pMCSG19 vector by ligation-independent cloning (LIC) to generate the plasmid pMCSG19-His-ALKBH1 (Donnelly et al., 2006) . Human ALKBH1 was then expressed in a BL21 (DE3) E. coli strain containing the plasmid pRK1037. Cells were induced with 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) for 24 hr at 16 C. The soluble fraction was purified using a Ni-NTA column (QIAGEN), a gel-filtration column Pharmacia) , and finally an ion-exchange column (PE 4.6/100, Mono Q). FLAG-tagged ALKBH1 was cloned into vector pcDNA 3.0 (between EcoRI and XhoI restriction enzyme cutting site). High-purity plasmids used for mammalian cell transfection were prepared using HiSpeed Plasmid Maxi Kit (QIAGEN).
The plasmid with site-directed mutagenesis was constructed using QuikChange II site-directed mutagenesis kit (QIAGEN). The following pair of primers were used: H231A/D233A_forward: GGAATCGCCGTAGCCAGATCTGAG H231A/D233A_reverse: CTCAGATCTGGCTACGGCGATTCC Reporter mutant 1: Lys8(CUU to UUU) Lys9(CUU to UUU) Gly10(GCC to CCC) Mutant1_forward: GAAAAACATTAAAAAAGGGCCAGCGCCATTCTACCCACTCGAAG Mutant1_reverse: GCATCTTCCATGGTGGCTTTACCAACAGTACCGGATTG Reporter mutant 2: Ala64(UGC to CGC) Ala66(AGC to CGC) Lys68(CUU to UUU) Mutant2_forward: TGGCGGAAGCGATGAAACGCTATGGGCTGAATACAAACCATC Mutant2_reverse: GCCGAACGCTCATCTCGAAGTACTCGGCGTAGGTAATG Mammalian Cell Culture, siRNA Knockdown (KD), and Plasmid Transfection HeLa cell line was purchased from ATCC (CCL-2) and grown in DMEM (GIBCO, 11965) media supplemented with 10% FBS (GIBCO, 10438-026) and 1 3 Pen/Strep (GIBCO, 15140). Transfections were performed using Lipofectamine RNAiMAX (Invitrogen) for siRNA knockdown, and Lipofectamine 2000 (Invitrogen) for plasmid transfection, respectively, following the manufacturer's procedure. Two synthesized duplex RNAi oligos targeting human ALKBH1 mRNA sequences were used: 5 0 -CCCGAGAGAUUCAAUGGUATT-3 0 and 5 0 -GGAUGACCAGAAUAGCGAATT-3 0 ; a scrambled duplex RNAi oligo (5 0 -UUCUCCGAACGUGUCACGU) was used as a negative control.
The Alkbh1 knockout MEF cell line and the control cell line as well as Alkbh1 knockout MES cell line and the control cell line were previously reported (Ougland et al., 2012) .
ALKBH1 Stable Overexpression HeLa Cell Line Construction
The plasmid for pMSCV-FLAG-HA-ALKBH1 expression was transfected into HeLa cells. The cells were selected under 1 mg/ml puromycin for two weeks. During the selection period, cells were resuspended every two days with fresh DMEM medium supplemented with 10% FBS and puromycin. After 7 days, the survived cells were separated as single cell in 96-well plate and subjected to puromycin selection for another 7 days. The survived cells from each of the 96-well plate were collected as monoclonal ALKBH1 stable overexpression HeLa cell lines. The expression of ALKBH1 was confirmed by using both anti-FLAG and anti-HA antibodies.
Glucose Deprivation
Cells were subjected to glucose deprivation (glucose-depleted medium supplemented with 2% FBS, 1 3 Pen/Strep, and 5 mM glucose) for 8 hr. The cells were subsequently harvested for western blot analysis; the tRNAs were extracted from the treated cells for LC-MS/MS analysis.
In the reporter assay, the experiments were carried out right after 8 hr of glucose starvation in ALKBH1 knockdown versus control cells, overexpression of ALKBH1 wild-type or inactive mutant ALKBH1 (H231A/D233A) versus control cells.
tRNA Isolation RNA species smaller than 200 nucleotides were extracted using mirVana miRNA Isolation Kit (Life Technologies). The small RNAs were further loaded onto a 15% TBE-Urea gel and the specific tRNA bands were sliced and recovered from the gel. Streptavidinconjugated M-280 magnetic Dynabeads (Invitrogen) were used for specific tRNA isolation. 20 ml of RNase-free beads were generated according to the manufacturer's instructions, washed once with buffer A (10 mM Tris-HCl, pH 7.5, 2 mM EDTA, 2 M NaCl), and finally resuspended in 20 ml of buffer A. Subsequently, 200 mM of biotinylated oligonucleotides in 10 ml of water were mixed with an equal volume of Dynabeads in buffer A and incubated at room temperature for 30 min with gentle mixing. After the incubation, the oligonucleotide-coated Dynabeads were then washed for four times in buffer B (5 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 M NaCl) and equilibrated in 6 3 SSC solution (1 3 SSC is 0.15 M NaCl plus 0.015 M sodium citrate, pH 7.0). The oligonucleotide-coated Dynabeads and total tRNA in 6 3 SSC solutions were heated for 10 min at 75 C before they were pooled and incubated together at 75 C for another 10 min. Thereafter, the suspension was placed at room temperature for 3 hr to allow binding of the tRNAs to the cDNA strands on the dynabeads. The oligonucleotide-coated Dynabeads were washed, in succession, three times with 3 3 SSC, twice with 1 3 SSC, and several times with 0.1 3 SSC until the absorbance of the wash solution at 260 nm was close to zero. tRNA retained on the beads was eluted three times using RNase-free water.
Biotinylated Single-Stranded DNA Probes DNA probes were designed to complement with the 3 0 gene sequences of tRNA Val(mAC) , tRNA Gly(GCC) , tRNA His(GUG) , tRNA Glu(CUC) , tRNA Gln(CUG) , tRNA Lys(yUU) , tRNA Tyr(GUA) , tRNA Ala(hGC) , tRNA iMet(CAU) , tRNA eMet(CAU) , tRNA Phe(GAA) , tRNA Sec(UCA) , and tRNA Asn(GUU) . Probe for tRNA Tyr(GUA) is located in the middle of the mature tRNA. Because human and mouse share identical sequences in these regions of the selected tRNAs, the same DNA probes were utilized for both human and mouse tRNA selection. The probes used for tRNA selection are listed below:
For tRNA Val(mAC) 
Biochemistry Assay of ALKBH1 Activity in vitro The demethylation activity assay was performed in standard 100 ml of reaction mixture containing ALKBH1 (2 nmol), TBE-Urea gel purified tRNA (400 ng), KCl (100 mM), MgCl 2 (2 mM), SUPERNase In (0.2 U/ml, life technology), L-ascorbic acid (2 mM), a-ketoglutarate (300 mM), (NH 4 ) 2 Fe(SO 4 ) 2 $6H 2 O (150 mM), and 50 mM of MOPS buffer (pH 6.5). The reaction was incubated overnight at 16 C, and quenched by addition of 5 mM of EDTA. 60 ml of phenol-chloroform was added to the reaction tube and mixed well (an equal volume of phenol/CHCl 3 must be always used). The water phase, which contained the RNA, was collected and subjected to ethanol precipitation. The pellet was finally dissolved into the desired amount of water and analyzed.
Biochemical demethylation assays of ALKBH1 toward m 1 A and m 6 A in single-stranded RNA (ssRNA) and 1mA and 6mA in doublestranded DNA (dsDNA) were conducted in 50 ml of reaction mixture containing 1 nmol ALKBH1, 100 ng probes, KCl (100 mM), MgCl 2 (2 mM), SUPERNase In (0.2 U/ml, life technology), L-ascorbic acid (2 mM), a-ketoglutarate (300 mM), (NH 4 ) 2 Fe(SO 4 ) 2 $6H 2 O (150 mM), and 50 mM of MOPS buffer (pH 6.5). The reaction was incubated at 37 C for 1 hr and quenched by addition of 5 mM of EDTA. The samples were then centrifuged at 13,000 g for 30 min. The supernatant was collected for RNA or DNA digestion prior to LC-MS/MS analysis.
For the steady-state kinetics of the ALKBH1-catalyzed demethylation of m 1 A in the stem-loop structured RNA and in unstructured RNA probes, all reactions were performed at 37 C with 50 mol% of ALKBH1 used. For the annealing of dsDNA, the complementary strands were kept at 10 mM and heated at 95 C for 3 min before cooling down to room temperature over 2 hr.
The sequences of the probes are listed below:
(1) 6mA-containing dsDNA oligo (#1): A Level Using LC-MS/MS 400 ng of tRNA, purified by using TBE-Urea gel, was digested by nuclease P1 (2 U) in 30 ml of buffer containing 25 mM of NaCl, and 2.5 mM of ZnCl 2 at 37 C for 1 hr, followed by the addition of NH 4 HCO 3 (100 mM) and alkaline phosphatase (0.5 U). After an additional incubation at 37 C for 1 hr, the solution was diluted to 100 ml, filtered through PVDF filter, and 10 ml of the solution was injected into HPLC-QQQ-MS/MS. Nucleosides were separated by reverse-phase ultra-performance liquid chromatography on a C18 column with online mass spectrometry detection using Agilent 6410 QQQ triple-quadruple LC mass spectrometer in positive electrospray ionization mode. The nucleosides were quantified using the nucleoside-to-base ion mass transitions of 282. 
Dot Blot Assay
In the dot-blot analysis, a m 1 A monoclonal antibody was used to measure the m 1 A levels in total tRNA of HeLa cells with transient overexpression of ALKBH1 versus control (empty vector pcDNA 3.0 transfection), in total tRNA of Alkbh1 À/À versus wild-type MEF cells, and in total tRNA of HeLa cells of ALKBH1 stable overexpression versus the control. tRNA was first isolated and denatured by heating at 95 C for 1 min, followed by chilling on ice directly. Two-fold serial dilutions were spotted on an Amersham Hybond-N + membrane optimized for nucleic acid binding (GE Healthcare). After UV crosslinking in a Stratagene Stratalinker 2400 UV Crosslinker, the membrane was washed by 1 3 PBST buffer, blocked with 5% of milk in 1 3 PBST, and incubated with anti-m 1 A monoclonal antibody (1: 1,000; MEDICAL&BIOLOGICAL LABORATORIES CO., LTD) overnight at 4 C. After incubating with horseradish peroxidase (HRP)-conjugated anti-mouse IgG secondary antibody, the membrane was visualized by ECL western Blotting Detection Kit (Thermo). To ensure an equal amount of mRNA was spotted on the membrane, the same blot was stained with 0.02% methylene blue in 0.3 M sodium acetate (pH 5.2).
To test the specificity of m 1 A antibody (1: 1,000; MEDICAL&BIOLOGICAL LABORATORIES CO., LTD) and m 6 A antibody (1: 2,000), we applied these antibodies to a synthesized oligonucleotide encoding an ACAUG sequence; the second A was in the form of unmodified A, m 6 A, and m 1 A, respectively.
Western Blot
The expression levels of ALKBH1 and the heterodimer TRMT6/TRMT61 in HeLa cells growing at different glucose concentrations were analyzed by western blot. HeLa cells were cultured at different glucose concentration for 8 hr before they were lysed and subjected to western blot analysis. Monoclonal rabbit anti-ALKBH1 antibody (Abcam, ab128895) was applied with a dilution of 1: 1,000 for western blot. Polyclonal rabbit anti-TRMT6 antibody (Sigma, SAB2107213) and polyclonal rabbit anti-TRMT61 antibody(Sigma SAB2700607) were both used with 1: 400 dilution. Monoclonal rabbit anti-eEF1a antibody (Abcam, ab157455) was used with 1: 1,000 dilution.
Cell Viability Assay
Cell viability was measured by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells with ALKBH1 knockdown and control cells were seeded into 96-well plate at equal quantity of 3,000 cells per well. MTT assay was conducted on every other day till the eighth day; 20 ml of MTT solution (1 mM) was added to each well and the mixture was incubated at 37 C for 4 hr. The solution in each well was aspirated. The resulted purple crystals were dissolved in 100 ml DMSO and subsequently transferred into a new 96-well plate for UV-Vis measurement. The absorbance at 620 nm was recorded and plotted.
Northern Blot
In the Northern blot analysis, 1 mg of total RNA was mixed with Novexâ TBE-Urea Sample Buffer (2 3 ) and heated at 95 C for 3 min. Samples were chilled on ice before being subjected to a 15% TEB-Urea gel for electrophoresis separation. After electrophoresis, the RNA was transferred to positively charged Amersham Hybond-N + membrane and subsequently immobilized by UV-crosslinking by using UV stratalinker 2400. The membrane was further subjected to prehybridization with buffer containing 5 3 SSC, 5 3 Denhardt'ssolution, 0.1% SDS; 100 mg/ml salmon sperm DNA for 2 hr prior to the incubation with 5 0 -32 P labeled tRNA detecting probes. After incubation, the membrane was washed several times with washing buffer containing 2 3 SSC and 0.5% SDS. The washed membrane was finally subjected to phosphoimager exposure.
In order to quantify the levels of tRNA iMet, His(GUG), Gly(GCC), Val(mAC) in ALKBH1 knockdown cells versus knockdown control cells, Alkbh1 knockout cells versus knockout control cells, total RNAs were extracted from cultured cells. 1mg of total RNAs were used for each sample in the Northern blot analysis. 5s rRNA was used as a loading control.
In order to quantify the levels of tRNA His(GUG) and tRNA Gly(GCC) in the translational active (> 80S) and inactive component (< 80S), the translational active and inactive components were separated using sucrose gradient. The total RNAs were extracted and then followed the aforementioned procedure. 5s rRNA was used as a loading control.
The sequences of the northern probes are listed below: Cells were treated with 50 mM Lactimidomycin (LTM) for 30 min. And then cells were harvested and lysed prior to size exclusion chromatography using MicroSpin S-400 HR Columns. 100 ml of cell lysate were saved as input. The collected flow-through from the size exclusion column contains the initiating ribosomes. The total RNAs from the whole cell lysate and the initiating ribosomes were extracted for Northern blot analysis. 5s rRNA was used as the loading control.
eEF1a Immunoprecipitation Three plates of HeLa cells were lysed and the supernatant was saved for immunoprecipitation. 50 ml of eEF1a antibody-conjugated protein A beads were subsequently added to the supernatant and kept at 4 C overnight with rotation. On the next day, one portion of the immunoprecipitated protein was subjected to western blot analysis to test eEF1a pull-down specificity. $300 ng eEF1a was incubated with 1 mg of tRNA purified from HeLa cells in 200 ml IPP buffer (150 mM NaCl, 0.1% NP-40, 10 mM Tris, pH 7.4, 40 U/ml RNase inhibitor, 0.5 mM DTT) for 2 hr. The unbound tRNA was also collected from the flow-through fraction. After three times of wash with IPP buffer, proteinase K was supplemented to the incubation pool to release the tRNAs that were bound to eEF1a. LC-MS/MS was used to measure the level of m 1 A in the tRNAs in the input, flow-through, and eEF1a-bound fractions.
Measurement of the Protein Synthesis Rate HPG (Life Technologies; 50 nM final concentration) was added to the culture medium, and incubated for 1 hr. Cells were then removed from plates and washed twice in Ca
2+
-and Mg 2+ -free phosphate buffered saline (PBS). Cells were fixed in 0.5 ml of 1% paraformaldehyde (Affymetrix) in PBS for 15 min on ice. Cells were washed in PBS, and permeabilized in 200 ml PBS supplemented with 3% fetal bovine serum (Sigma) and 0.1% saponin (Sigma) for 5 min at room temperature. The azide-alkyne reaction was performed with the Click-iT Cell Reaction Buffer Kit (Life Technologies) and azide-modified Alexa Fluor 488 (Life Technologies) at 5 mM final concentration. After a 30 min reaction, cells were washed twice in 3% BSA. All cells were filtered through a 40-mm cell strainer to obtain single cell suspensions. For flow cytometric analysis, all sorted fractions were double sorted to ensure high purity. Data were analyzed by FlowJo (Tree Star) software.
QUANTIFICATION AND STATISTICAL ANALYSIS
p values were determined using two-tailed Student's t test for paired samples. *p < 0.05, **p < 0.01. Error bars represent mean ± SD. n.s. means not significant.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the high-throughput sequencing data reported in this paper is GEO: GSE65299 (see also Table S2 ).
